Glacier FarmMedia COVID-19 & the Farm

Global Markets: India records new daily high in COVID-19 cases

WINNIPEG – The following is a glance at the news moving markets in Canada and globally.

     – For the fifth straight day, the number of new COVID-19 cases in India reached a record-high on Monday with 352,991 newly identified as having the virus. Over that same period, there have been 2,812 new deaths. Yesterday, the United States announced it was temporarily lifting a ban on sending raw materials for vaccines to India. U.S. officials also announced the country will send medical equipment and protective gear for India’s front-line workers.

– Canada will receive shipments totalling 1.9 million doses of the COVID-19 vaccine this week, the federal government announced. More than one million doses from Pfizer-BioNTech, 650,000 shots from Moderna and the first 300,000 doses of Johnson & Johnson’s vaccine will be sent. However, there will be no doses of AstraZeneca’s vaccine despite the National Advisory Committee on Immunization expanding age eligibility to 30 and over for the shot.

– Dock workers at the Port of Montreal plan to go ahead with a strike this morning, disrupting business at Canada’s second-largest port. Meanwhile, the federal government will draft a notice paper in an attempt to expedite back-to-work legislation. A bill is expected to be tabled by Labour Minister Filomena Tassi by Wednesday. “Putting forward this notice is our government’s least-favoured option. We believe in the collective bargaining process,” Tassi said in a string of tweets on Sunday. “However, the government must act when all other efforts have been exhausted and a work stoppage is causing significant economic harm to Canadians.”

COPA Medallion COPA finalist in 2012, 2014 and 2015.
©2021 AGCanada is a production of Glacier FarmMedia Limited Partnership. Any affiliated or third party content is the property of its respective owner and is used with permission.
Please refer to Copyright Page for details.
Click here to view our Website Terms of Use.